Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Publication list

publication_uri type publication_title year doi pmid journal_uri
http://vivo.scripps.edu/individual/endnote69238 AcademicArticle High-sensitivity c-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the charisma trial 2011 10.1136/hrt.2010.210419 21393433 http://vivo.scripps.edu/individual/endnote239917
http://vivo.scripps.edu/individual/endnote384871 AcademicArticle Effect of clopidogrel plus asa vs. Asa early after tia and ischaemic stroke: A substudy of the charisma trial 2011 10.1111/j.1747-4949.2010.00535.x 21205234 http://vivo.scripps.edu/individual/endnote108453
http://vivo.scripps.edu/individual/endnote298521 AcademicArticle Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients a prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (charisma) trial 2010 10.1161/strokeaha.110.586727 20595658 http://vivo.scripps.edu/individual/endnote303530
http://vivo.scripps.edu/individual/endnote41094 AcademicArticle Aspirin to prevent cardiovascular disease: The association of aspirin dose and clopidogrel with thrombosis and bleeding 2009 10.7326/0003-4819-150-6-200903170-00006 19293071 http://vivo.scripps.edu/individual/endnote317144
http://vivo.scripps.edu/individual/endnote188159 AcademicArticle Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (charisma) study 2009 10.1016/j.ahj.2008.08.031 19332192 http://vivo.scripps.edu/individual/endnote50170
http://vivo.scripps.edu/individual/endnote73086 AcademicArticle The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease 2009 10.1093/eurheartj/ehp037 19233855 http://vivo.scripps.edu/individual/endnote137021
http://vivo.scripps.edu/individual/endnote221528 AcademicArticle Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: Subgroup analysis of the charisma randomized trial 2008 10.1159/000118380 18303254 http://vivo.scripps.edu/individual/endnote89261
http://vivo.scripps.edu/individual/endnote296485 AcademicArticle Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid determinants and effect on cardiovascular risk 2008 10.1161/circulationaha.108.768283 18838564 http://vivo.scripps.edu/individual/endnote329477
http://vivo.scripps.edu/individual/endnote95086 AcademicArticle Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the charisma trial 2007 10.1016/j.jacc.2007.03.025 17498584 http://vivo.scripps.edu/individual/endnote242173
http://vivo.scripps.edu/individual/endnote247642 AcademicArticle Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events 2006 10.1056/NEJMoa060989 16531616 http://vivo.scripps.edu/individual/endnote83648
http://vivo.scripps.edu/individual/endnote120017 AcademicArticle A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial 2005 10.1016/j.ahj.2005.03.017 16169314 http://vivo.scripps.edu/individual/endnote50170

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support